Commentary: tumor growth, patient survival, and the search for the optimal phase II efficacy endpoint
- PMID: 18832191
- DOI: 10.1634/theoncologist.2008-0180
Commentary: tumor growth, patient survival, and the search for the optimal phase II efficacy endpoint
Comment on
-
Tumor growth rates derived from data for patients in a clinical trial correlate strongly with patient survival: a novel strategy for evaluation of clinical trial data.Oncologist. 2008 Oct;13(10):1046-54. doi: 10.1634/theoncologist.2008-0075. Epub 2008 Oct 6. Oncologist. 2008. PMID: 18838440 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
